A cost-effectiveness evaluation of a jail-based Chlamydia screening program for men and its impact on their partners in the community

被引:19
作者
Gift, Thomas L.
Lincoln, Thomas
Tuthill, Robert
Whelan, Michael
Briggs, L. Patricia
Conklin, Thomas
Irwin, Kathleen L.
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] Baystate Med Ctr, Springfield, MA USA
[3] Tufts Univ, Sch Med, Springfield, MA 01199 USA
[4] Hampden Cty Correct Ctr, Ludlow, MA USA
[5] Univ Massachusetts, Sch Publ Hlth, Amherst, MA 01003 USA
[6] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA
关键词
D O I
10.1097/01.olq.0000235169.45680.7c
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Few cost-effectiveness evaluations of screening men in jails for chlamydia have been published, and none have evaluated the cost-effectiveness of providing partner notification services to the partners of chlamydia-infected inmates. Goal: The goal of this study was to evaluate the cost-effectiveness of the chlamydia screening and partner notification programs for men conducted by a Massachusetts jail compared with 3 hypothetical alternatives. Study Design: Using jail cost and testing data, we used decision analyses to compare the cost and effectiveness of universal screening, age-based screening with 2 age cutoffs, and testing of symptomatic inmates at intake using treated cases of chlamydia and gonorrhea as the primary outcome. We also evaluated the cost-effectiveness of adding partner notification to these alternatives. Results: Universal screening was the most effective and expensive alternative. Age-based screening would have identified slightly fewer cases at half the cost of universal screening. The net cost of partner notification was low. Assuming high sequelae costs in female partners made partner notification a cost-saving intervention. Conclusions: Age-based screening could lower costs without substantially sacrificing effectiveness. Notifying partners of infected inmates was a cost-effective adjunct to screening inmates.
引用
收藏
页码:S103 / S110
页数:8
相关论文
共 50 条
[21]  
Hook E.W., 1999, SEX TRANSM DIS, P451
[22]   Women for Chlamydia trachomatis in family planning clinics - The cost-effectiveness of DNA amplification assays [J].
Howell, MR ;
Quinn, TC ;
Brathwaite, W ;
Gaydos, CA .
SEXUALLY TRANSMITTED DISEASES, 1998, 25 (02) :108-117
[23]   Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men [J].
Johnson, RE ;
Green, TA ;
Schachter, J ;
Jones, RB ;
Hook, EW ;
Black, CM ;
Martin, DH ;
St Louis, ME ;
Stamm, WE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (12) :4382-4386
[24]   Gonorrhoea and chlamydia core groups and sexual networks in Manitoba [J].
Jolly, AM ;
Wylie, JL .
SEXUALLY TRANSMITTED INFECTIONS, 2002, 78 :I145-I151
[25]   Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests:: A performance review with clinical and public health considerations [J].
Koumans, EH ;
Johnson, RE ;
Knapp, JS ;
St Louis, ME .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1171-1180
[26]   Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails [J].
Kraut-Becher, JR ;
Gift, TL ;
Haddix, AC ;
Irwin, KL ;
Greifinger, RB .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2004, 81 (03) :453-471
[27]   Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis [J].
Magid, D ;
Douglas, JM ;
Schwartz, JS .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (04) :389-+
[28]   A CONTROLLED TRIAL OF A SINGLE DOSE OF AZITHROMYCIN FOR THE TREATMENT OF CHLAMYDIAL URETHRITIS AND CERVICITIS [J].
MARTIN, DH ;
MROCZKOWSKI, TF ;
DALU, ZA ;
MCCARTY, J ;
JONES, RB ;
HOPKINS, SJ ;
JOHNSON, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (13) :921-925
[29]  
*MED EC CO INC, 2001, 2001 DRUG TOP RED BO
[30]   Findings from STD screening of adolescents and adults entering corrections facilities - Implications for STD control strategies [J].
Mertz, KJ ;
Voigt, RA ;
Hutchins, K ;
Levine, WFC .
SEXUALLY TRANSMITTED DISEASES, 2002, 29 (12) :834-839